TCL Archive Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter October 15, 1976
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012